首页 > 最新文献

Journal of the International Association of Providers of AIDS Care最新文献

英文 中文
Clinical Outcomes of a Nurse-Delivered, Technology-Enabled HIV Outpatient Model. 由护士提供的技术辅助型艾滋病门诊模式的临床效果。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241274304
Sara Day, Rebecca Wilkins, Andrew Murungi, Christina Antoniadi, Yodit Fissahaye-Yimer, Samuel Ohene-Adomako, David Asboe, Caroline Rae

We evaluated Klick, a nurse-led, digitally enabled model of HIV outpatient care, launched in 2020. Klick's smartphone app offers online booking, remote nurse-led consultations, and results. An audit of Klick nurse-led consultations was conducted against BHIVA monitoring guidelines, and nurses were interviewed about their experience. Of 40 Klick patients audited, 4 of 5 BHIVA standards were met: 100% had documented co-medications, smoking history, blood pressure, and viral load data, and 89% received a cardiovascular risk calculation (Targets 97%-90%-90%-90%-90%). Compared to national BHIVA audit findings, Klick performed better across 22 of 24 comparable measures. Nurses safely managed a cohort comprising some complexity (eg, co-morbidities, polypharmacy); no cases were escalated off the pathway, and all were virologically suppressed. Using a digitally supported model, nurses effectively provided safe care to HIV-positive patients with predominantly stable health, enabling consultants to focus on more complex caseloads. Care was comprehensive and person-centered and obtained better outcomes compared to previous national audits.

我们对 Klick 进行了评估,这是一种以护士为主导的数字化艾滋病门诊护理模式,于 2020 年推出。Klick 的智能手机应用程序提供在线预约、远程护士咨询和结果。我们根据 BHIVA 监测指南对 Klick 护士主导的咨询进行了审核,并就护士的经验进行了访谈。在接受审核的 40 名 Klick 患者中,有 4 人达到了 BHIVA 的 5 项标准:100%的患者记录了共同用药、吸烟史、血压和病毒载量数据,89%的患者接受了心血管风险计算(目标97%-90%-90%-90%-90%)。与全国 BHIVA 审计结果相比,克里克在 24 项可比指标中的 22 项指标上表现更佳。护士们安全地管理了一批具有一定复杂性的患者(如合并疾病、多重药物治疗);没有病例脱离治疗路径,而且所有病例都得到了病毒抑制。利用数字化支持模式,护士有效地为健康状况基本稳定的 HIV 阳性患者提供了安全护理,使顾问能够专注于更复杂的病例。护理工作全面且以人为本,与之前的全国性审计相比,取得了更好的成果。
{"title":"Clinical Outcomes of a Nurse-Delivered, Technology-Enabled HIV Outpatient Model.","authors":"Sara Day, Rebecca Wilkins, Andrew Murungi, Christina Antoniadi, Yodit Fissahaye-Yimer, Samuel Ohene-Adomako, David Asboe, Caroline Rae","doi":"10.1177/23259582241274304","DOIUrl":"10.1177/23259582241274304","url":null,"abstract":"<p><p>We evaluated Klick, a nurse-led, digitally enabled model of HIV outpatient care, launched in 2020. Klick's smartphone app offers online booking, remote nurse-led consultations, and results. An audit of Klick nurse-led consultations was conducted against BHIVA monitoring guidelines, and nurses were interviewed about their experience. Of 40 Klick patients audited, 4 of 5 BHIVA standards were met: 100% had documented co-medications, smoking history, blood pressure, and viral load data, and 89% received a cardiovascular risk calculation (Targets 97%-90%-90%-90%-90%). Compared to national BHIVA audit findings, Klick performed better across 22 of 24 comparable measures. Nurses safely managed a cohort comprising some complexity (eg, co-morbidities, polypharmacy); no cases were escalated off the pathway, and all were virologically suppressed. Using a digitally supported model, nurses effectively provided safe care to HIV-positive patients with predominantly stable health, enabling consultants to focus on more complex caseloads. Care was comprehensive and person-centered and obtained better outcomes compared to previous national audits.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241274304"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11440533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of the UNAIDS Incidence Patterns Model to Determine the Distribution of New HIV Infection in Lagos State, Nigeria. 应用联合国艾滋病规划署发病模式模型确定尼日利亚拉各斯州艾滋病毒新感染者的分布情况。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241238653
Toriola Femi-Adebayo, Monsurat Adeleke, Bisola Adebayo, Temitope Fadiya, Bukola Popoola, Opeyemi Ogundimu, Funmilade O Adepoju, Ayotomiwa Salawu, Oladipupo Fisher, Olusegun Ogboye, Leopold Zekeng

Background: Identifying patterns in the distribution of new HIV infections in the population is critical for HIV programmatic interventions. This study aimed to determine the distribution of New HIV infection by applying the incidence patterns mathematical model to data from Lagos state.

Methods: The incidence patterns model (IPM) software is a mathematical model developed by UNAIDS to estimate the demographic and epidemic patterns of HIV infections. This model was adapted in Lagos state to predict the distribution of new HIV infections among specified risk groups in the next 12 months.

Results: The IPM predicted a total HIV incidence of 37 cases per 100 000 individuals (3979 new infections) will occur among the 15 to 49 subpopulations. The results also showed that sero-concordant HIV-negative couples with external partners (29%), female sex workers (26%), men-having-sex-with-men (18%), and previously married females (6%) accounted for the majority of the estimated new HIV infections. Overall, key populations constitute almost half (48%) of the estimated number of new HIV infections.

Conclusion: The study helped to identify the population groups contributing significantly to new HIV infections. Therefore, priority interventions should be focused on these groups.

背景:确定艾滋病毒新感染者在人群中的分布模式对于艾滋病毒计划干预至关重要。本研究旨在通过将发病模式数学模型应用于拉各斯州的数据,确定艾滋病毒新感染者的分布情况:发病模式模型 (IPM) 软件是联合国艾滋病规划署开发的一种数学模型,用于估算艾滋病病毒感染的人口和流行模式。拉各斯州对该模型进行了调整,以预测未来 12 个月特定风险人群中新感染艾滋病毒的分布情况:根据 IPM 预测,在 15 至 49 岁的亚人群中,艾滋病毒总发病率为每 10 万人 37 例(3979 例新感染病例)。结果还显示,与外部伴侣血清一致的艾滋病毒阴性夫妇(29%)、女性性工作者(26%)、男男性行为者(18%)和已婚女性(6%)占艾滋病毒新感染者估计数的大多数。总体而言,重点人群占艾滋病毒新感染者估计人数的近一半(48%):这项研究有助于确定对新增艾滋病毒感染有重大影响的人群。因此,应优先对这些群体采取干预措施。
{"title":"Application of the UNAIDS Incidence Patterns Model to Determine the Distribution of New HIV Infection in Lagos State, Nigeria.","authors":"Toriola Femi-Adebayo, Monsurat Adeleke, Bisola Adebayo, Temitope Fadiya, Bukola Popoola, Opeyemi Ogundimu, Funmilade O Adepoju, Ayotomiwa Salawu, Oladipupo Fisher, Olusegun Ogboye, Leopold Zekeng","doi":"10.1177/23259582241238653","DOIUrl":"10.1177/23259582241238653","url":null,"abstract":"<p><strong>Background: </strong>Identifying patterns in the distribution of new HIV infections in the population is critical for HIV programmatic interventions. This study aimed to determine the distribution of New HIV infection by applying the incidence patterns mathematical model to data from Lagos state.</p><p><strong>Methods: </strong>The incidence patterns model (IPM) software is a mathematical model developed by UNAIDS to estimate the demographic and epidemic patterns of HIV infections. This model was adapted in Lagos state to predict the distribution of new HIV infections among specified risk groups in the next 12 months.</p><p><strong>Results: </strong>The IPM predicted a total HIV incidence of 37 cases per 100 000 individuals (3979 new infections) will occur among the 15 to 49 subpopulations. The results also showed that sero-concordant HIV-negative couples with external partners (29%), female sex workers (26%), men-having-sex-with-men (18%), and previously married females (6%) accounted for the majority of the estimated new HIV infections. Overall, key populations constitute almost half (48%) of the estimated number of new HIV infections.</p><p><strong>Conclusion: </strong>The study helped to identify the population groups contributing significantly to new HIV infections. Therefore, priority interventions should be focused on these groups.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241238653"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10956134/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140175173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Frailty Phenotypes in Older People Living with HIV: A Cross-Sectional Study from Brazil. 巴西一项横断面研究:感染艾滋病毒的老年人中虚弱表型的流行率:巴西的一项横断面研究
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241241169
Susana Lilian Wiechmann, Alexandre Mestre Tejo, Manuel Victor Silva Inácio, Arthur Eumann Mesas, Marcos Aparecido Sarria Cabrera

Background: Frailty may affect people living with HIV (PLHIV) prematurely. Fried's frailty phenotype, composed of 5 criteria, is one of the most used instruments for its assessment. This study aimed to determine the prevalence of these criteria among PLHIV classified as prefrail and frail in Brazil.

Methods: A cross-sectional study analyzed the prevalence of the Frailty Phenotype in Brazil with 670 individuals aged ≥ 50 years and undetectable viral load.

Results: The prevalence of prefrail and frail individuals was 50.7% and 13.6%, respectively. A low level of physical activity was the most prevalent criterion (50.9%). Except for unintentional weight loss, all other criteria were more prevalent among individuals with lower education levels. All criteria were more prevalent among individuals of lower socioeconomic status than among those of moderate or high status (P < .05).

Conclusions: A low level of physical activity was the component that most contributed to PLHIV being considered prefrail or frail.

背景:虚弱可能会过早影响艾滋病病毒感染者(PLHIV)。弗里德虚弱表型由 5 项标准组成,是最常用的评估工具之一。本研究旨在确定这些标准在巴西被归类为前体弱和体弱的艾滋病毒感染者中的流行率:一项横断面研究分析了巴西 670 名年龄≥ 50 岁且病毒载量检测不到的个体中体弱表型的流行情况:结果:体弱前型和体弱后型的患病率分别为 50.7% 和 13.6%。体力活动少是最普遍的标准(50.9%)。除无意中体重减轻外,所有其他标准在受教育程度较低的人群中都更为普遍。所有标准在社会经济地位较低的人群中都比在社会经济地位中等或较高的人群中更普遍(P 结 论):体力活动水平低是导致艾滋病毒感染者被认为是体弱多病的最主要因素。
{"title":"Prevalence of Frailty Phenotypes in Older People Living with HIV: A Cross-Sectional Study from Brazil.","authors":"Susana Lilian Wiechmann, Alexandre Mestre Tejo, Manuel Victor Silva Inácio, Arthur Eumann Mesas, Marcos Aparecido Sarria Cabrera","doi":"10.1177/23259582241241169","DOIUrl":"10.1177/23259582241241169","url":null,"abstract":"<p><strong>Background: </strong>Frailty may affect people living with HIV (PLHIV) prematurely. Fried's frailty phenotype, composed of 5 criteria, is one of the most used instruments for its assessment. This study aimed to determine the prevalence of these criteria among PLHIV classified as prefrail and frail in Brazil.</p><p><strong>Methods: </strong>A cross-sectional study analyzed the prevalence of the Frailty Phenotype in Brazil with 670 individuals aged ≥ 50 years and undetectable viral load.</p><p><strong>Results: </strong>The prevalence of prefrail and frail individuals was 50.7% and 13.6%, respectively. A low level of physical activity was the most prevalent criterion (50.9%). Except for unintentional weight loss, all other criteria were more prevalent among individuals with lower education levels. All criteria were more prevalent among individuals of lower socioeconomic status than among those of moderate or high status (<i>P</i> < .05).</p><p><strong>Conclusions: </strong>A low level of physical activity was the component that most contributed to PLHIV being considered prefrail or frail.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241241169"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11078087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140876726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Implications of HIV Treatment and Prevention for Polygamous Families in Kenya and Uganda: "My Co-Wife Is the One Who Used to Encourage Me". 肯尼亚和乌干达一夫多妻制家庭艾滋病治疗和预防的临床意义:"我的同妻曾经鼓励过我"。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241255171
Jason Johnson-Peretz, Anjeline Onyango, Sarah A Gutin, Laura Balzer, Cecilia Akatukwasa, Lawrence Owino, Titus M O Arunga, Fred Atwine, Maya Petersen, Moses Kamya, James Ayieko, Ted Ruel, Diane Havlir, Carol S Camlin

Polygamy is the practice of marriage to multiple partners. Approximately 6-11% of households in Uganda and 4-11% of households in Kenya are polygamous. The complex families produced by polygamous marriage customs give rise to additional considerations for healthcare providers and public health messaging around HIV care. Using 27 in-depth, semi-structured qualitative interviews with participants in two studies in rural Kenya and Uganda, we analysed challenges and opportunities that polygamous families presented in the diagnosis, treatment and prevention of HIV, and provider roles in improving HIV outcomes in these families. Overall, prevention methods seemed more justifiable to families where co-wives live far apart than when all members live in the same household. In treatment, diagnosis of one member did not always lead to disclosure to other members, creating an adverse home environment; but sometimes diagnosis of one wife led not only to diagnosis of the other, but also to greater household support.

一夫多妻制是与多个伴侣结婚的习俗。乌干达约有 6-11% 的家庭和肯尼亚约有 4-11% 的家庭实行一夫多妻制。一夫多妻制婚姻习俗所产生的复杂家庭给医疗服务提供者和围绕艾滋病护理的公共卫生信息提供者带来了更多的考虑。通过对肯尼亚和乌干达农村地区两项研究的参与者进行 27 次深入的半结构化定性访谈,我们分析了一夫多妻制家庭在诊断、治疗和预防艾滋病方面所面临的挑战和机遇,以及医疗服务提供者在改善这些家庭艾滋病治疗效果方面所扮演的角色。总体而言,与所有成员都生活在同一个家庭相比,预防方法似乎更适用于共同妻子分居两地的家庭。在治疗方面,对一名成员的诊断并不总是导致向其他成员披露,从而造成不利的家庭环境;但有时对一名妻子的诊断不仅导致对另一名妻子的诊断,而且还带来了更多的家庭支持。
{"title":"Clinical Implications of HIV Treatment and Prevention for Polygamous Families in Kenya and Uganda: \"My Co-Wife Is the One Who Used to Encourage Me\".","authors":"Jason Johnson-Peretz, Anjeline Onyango, Sarah A Gutin, Laura Balzer, Cecilia Akatukwasa, Lawrence Owino, Titus M O Arunga, Fred Atwine, Maya Petersen, Moses Kamya, James Ayieko, Ted Ruel, Diane Havlir, Carol S Camlin","doi":"10.1177/23259582241255171","DOIUrl":"10.1177/23259582241255171","url":null,"abstract":"<p><p>Polygamy is the practice of marriage to multiple partners. Approximately 6-11% of households in Uganda and 4-11% of households in Kenya are polygamous. The complex families produced by polygamous marriage customs give rise to additional considerations for healthcare providers and public health messaging around HIV care. Using 27 in-depth, semi-structured qualitative interviews with participants in two studies in rural Kenya and Uganda, we analysed challenges and opportunities that polygamous families presented in the diagnosis, treatment and prevention of HIV, and provider roles in improving HIV outcomes in these families. Overall, prevention methods seemed more justifiable to families where co-wives live far apart than when all members live in the same household. In treatment, diagnosis of one member did not always lead to disclosure to other members, creating an adverse home environment; but sometimes diagnosis of one wife led not only to diagnosis of the other, but also to greater household support.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241255171"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140945415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transfusion-Transmissible Infections Among Blood Donors in a Regional Hospital in Ghana: A 6-Year Trend Analysis (2017-2022). 加纳一家地区医院献血者中的输血传播性传染病:6年趋势分析(2017-2022年)》。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241274305
Priscilla Yeboah Hadfield, Godwin Adjei Vechey, Emmanuel Bansah, Morkporkpor Nyahe, Nelisiwe Khuzwayo, Elvis Enowbeyang Tarkang

Background: This study determined the trends of transfusion-transmissible infections (TTIs) among blood donors in a regional hospital in Ghana from 2017 to 2022.

Methods: A retrospective analysis was conducted on 6339 blood donor records. Data were analyzed using STATA version 17.0 at the 0.05 significance level.

Results: The prevalence of TTIs was 31.4% in 2017, 13.8% in 2018, 20.4% in 2019, 9.5% in 2020, 9.6% in 2021, and 11.7% in 2022. There were significant associations between hepatitis C virus (HCV), Syphilis, and sex (OR = 2.06; 95% CI [1.29-3.30]; P = .003) and (OR = 2.28; 95% CI [1.48-3.54]; P < .001), respectively. Blood donors aged 20-29 were more likely to be infected with hepatitis B virus (OR = 1.96; 95% CI [1.28-2.99]; P = .002). Blood donors aged 40-49 had higher odds of infection with HCV (OR = 3.36; 95% CI [2.02-5.57]; P < .001) and Syphilis (OR = 3.79; 95% CI [2.45-5.87]; P < .001).

Conclusion: The study highlights the need to implement targeted prevention strategies for donors with a higher TTI prevalence.

背景:本研究确定了2017年至2022年加纳一家地区医院献血者中输血传播感染(TTIs)的趋势:对 6339 份献血者记录进行了回顾性分析。数据采用 STATA 17.0 版进行分析,显著性水平为 0.05:2017年TTI的患病率为31.4%,2018年为13.8%,2019年为20.4%,2020年为9.5%,2021年为9.6%,2022年为11.7%。丙型肝炎病毒(HCV)、梅毒与性别(OR = 2.06;95% CI [1.29-3.30];P = .003)和(OR = 2.28;95% CI [1.48-3.54];P P = .002)之间存在明显关联。40-49 岁献血者感染 HCV 的几率更高(OR = 3.36;95% CI [2.02-5.57];P P 结论:本研究强调了对 TTI 感染率较高的献血者实施有针对性的预防策略的必要性。
{"title":"Transfusion-Transmissible Infections Among Blood Donors in a Regional Hospital in Ghana: A 6-Year Trend Analysis (2017-2022).","authors":"Priscilla Yeboah Hadfield, Godwin Adjei Vechey, Emmanuel Bansah, Morkporkpor Nyahe, Nelisiwe Khuzwayo, Elvis Enowbeyang Tarkang","doi":"10.1177/23259582241274305","DOIUrl":"10.1177/23259582241274305","url":null,"abstract":"<p><strong>Background: </strong>This study determined the trends of transfusion-transmissible infections (TTIs) among blood donors in a regional hospital in Ghana from 2017 to 2022.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 6339 blood donor records. Data were analyzed using STATA version 17.0 at the 0.05 significance level.</p><p><strong>Results: </strong>The prevalence of TTIs was 31.4% in 2017, 13.8% in 2018, 20.4% in 2019, 9.5% in 2020, 9.6% in 2021, and 11.7% in 2022. There were significant associations between hepatitis C virus (HCV), Syphilis, and sex (OR = 2.06; 95% CI [1.29-3.30]; <i>P</i> = .003) and (OR = 2.28; 95% CI [1.48-3.54]; <i>P</i> < .001), respectively. Blood donors aged 20-29 were more likely to be infected with hepatitis B virus (OR = 1.96; 95% CI [1.28-2.99]; <i>P</i> = .002). Blood donors aged 40-49 had higher odds of infection with HCV (OR = 3.36; 95% CI [2.02-5.57]; <i>P</i> < .001) and Syphilis (OR = 3.79; 95% CI [2.45-5.87]; <i>P</i> < .001).</p><p><strong>Conclusion: </strong>The study highlights the need to implement targeted prevention strategies for donors with a higher TTI prevalence.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241274305"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11342317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142036174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapid Start of Antiretroviral Therapy in a Large Urban Clinic in the US South: Impact on HIV Care Continuum Outcomes and Medication Adherence. 在美国南部一个大型城市诊所快速启动抗逆转录病毒疗法:对艾滋病连续治疗结果和用药依从性的影响》(HIV Care Continuum Results and Medication Adherence)。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241228164
Jeremy Y Chow, Ang Gao, Chul Ahn, Ank E Nijhawan

Rapid start of antiretroviral therapy (ART) has been associated with improvement in several HIV-related outcomes in clinical trials as well as demonstration projects, but how regional and contextual differences may affect the effectiveness of this intervention necessitates further study. In this study of a large, urban, Southern US clinic-based retrospective cohort, we identified 544 patients with a new diagnosis of HIV during 2016 to 2019 and compared HIV care continuum outcomes for the first 12 months of care before and after rapid start implementation. Kaplan-Meier time-to-event curves were used to summarize time to virologic suppression, and stepwise Cox, linear, and logistic regression models were used to create multivariate models to evaluate the association between rapid start and time to virologic suppression, medication adherence, and retention in care and sustained virologic suppression, respectively. We found that rapid start was significantly associated with improved medication adherence scores (+15.37 points, 95% confidence interval [CI] 9.36-21.39, P < .01) and retention in care (adjusted odds ratio = 1.51, 95% CI 1.05-2.19, P = .03). Time to virologic suppression (median 2.46 months before, 2.56 months after rapid start) and sustained virologic suppression were not associated with rapid start in our setting. Though rapid start was associated with improved medication adherence and retention in care, more support may be needed to achieve the same outcomes seen in other studies and sustained over the entire HIV care continuum, especially in settings with significant patient and systemic barriers to care such as unstable housing, lack of Medicaid expansion, and frequent coverage interruptions.

在临床试验和示范项目中,抗逆转录病毒疗法(ART)的快速启动与多种艾滋病相关结果的改善有关,但地区和环境差异会如何影响这一干预措施的有效性,还需要进一步研究。在这项以美国南部大型城市诊所为基础的回顾性队列研究中,我们确定了 544 名在 2016 年至 2019 年期间新诊断出艾滋病的患者,并比较了快速启动实施前后前 12 个月的艾滋病护理连续性结果。我们使用 Kaplan-Meier 时间到事件曲线来总结病毒学抑制时间,并使用逐步 Cox、线性和逻辑回归模型来创建多变量模型,分别评估快速启动与病毒学抑制时间、药物依从性、护理保留率和持续病毒学抑制之间的关联。我们发现,快速起始与用药依从性评分的提高有明显关系(+15.37 分,95% 置信区间 [CI] 9.36-21.39,P P = .03)。在我们的研究中,病毒学抑制时间(快速启动前的中位数为 2.46 个月,快速启动后为 2.56 个月)和持续病毒学抑制与快速启动无关。虽然快速启动与改善服药依从性和坚持治疗有关,但可能需要更多的支持才能取得与其他研究相同的结果,并在整个艾滋病治疗过程中持续保持,尤其是在患者和系统性治疗障碍严重的环境中,如住房不稳定、医疗补助计划缺乏扩展以及保险频繁中断等。
{"title":"Rapid Start of Antiretroviral Therapy in a Large Urban Clinic in the US South: Impact on HIV Care Continuum Outcomes and Medication Adherence.","authors":"Jeremy Y Chow, Ang Gao, Chul Ahn, Ank E Nijhawan","doi":"10.1177/23259582241228164","DOIUrl":"10.1177/23259582241228164","url":null,"abstract":"<p><p>Rapid start of antiretroviral therapy (ART) has been associated with improvement in several HIV-related outcomes in clinical trials as well as demonstration projects, but how regional and contextual differences may affect the effectiveness of this intervention necessitates further study. In this study of a large, urban, Southern US clinic-based retrospective cohort, we identified 544 patients with a new diagnosis of HIV during 2016 to 2019 and compared HIV care continuum outcomes for the first 12 months of care before and after rapid start implementation. Kaplan-Meier time-to-event curves were used to summarize time to virologic suppression, and stepwise Cox, linear, and logistic regression models were used to create multivariate models to evaluate the association between rapid start and time to virologic suppression, medication adherence, and retention in care and sustained virologic suppression, respectively. We found that rapid start was significantly associated with improved medication adherence scores (+15.37 points, 95% confidence interval [CI] 9.36-21.39, <i>P</i> < .01) and retention in care (adjusted odds ratio = 1.51, 95% CI 1.05-2.19, <i>P</i> = .03). Time to virologic suppression (median 2.46 months before, 2.56 months after rapid start) and sustained virologic suppression were not associated with rapid start in our setting. Though rapid start was associated with improved medication adherence and retention in care, more support may be needed to achieve the same outcomes seen in other studies and sustained over the entire HIV care continuum, especially in settings with significant patient and systemic barriers to care such as unstable housing, lack of Medicaid expansion, and frequent coverage interruptions.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241228164"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10832401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139651066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dissemination of the Women-Centred HIV Care Model: A Multimodal Process and Evaluation. 传播以妇女为中心的艾滋病护理模式:多模式过程与评估。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582231226036
Jill Koebel, Mina Kazemi, V Logan Kennedy, Priscilla Medeiros, Breklyn Bertozzi, Lindsay Bevan, Wangari Tharao, Carmen H Logie, Angela Underhill, Neora Pick, Elizabeth King, Mary Kestler, Mark H Yudin, Jesleen Rana, Adriana Carvalhal, Kath Webster, Melanie Lee, Shaz Islam, Valerie Nicholson, Mary Ndung'u, Manjulaa Narasimhan, Brenda Gagnier, Muluba Habanyama, Alexandra de Pokomandy, Angela Kaida, Mona Loutfy

Background: Using data from a national cohort study and focus groups, the Women-Centred HIV Care (WCHC) Model was developed to inform care delivery for women living with HIV.

Methods: Through an evidence-based, integrated knowledge translation approach, we developed 2 toolkits based on the WCHC Model for service providers and women living with HIV in English and French (Canada's national languages). To disseminate, we distributed printed advertising materials, hosted 3 national webinars and conducted 2 virtual capacity-building training series.

Results: A total of 315 individuals attended the webinars, and the average WCHC knowledge increased by 29% (SD 4.3%). In total, 131 service providers engaged in 22 virtual capacity-building training sessions with 21 clinical cases discussed. Learners self-reported increased confidence in 15/15 abilities, including the ability to provide WCHC. As of December 2023, the toolkits were downloaded 7766 times.

Conclusions: We successfully developed WCHC toolkits and shared them with diverse clinical and community audiences through various dissemination methods.

背景:利用一项全国性队列研究和焦点小组的数据,开发了以女性为中心的艾滋病护理(WCHC)模式,为女性艾滋病感染者提供护理服务:通过循证、综合知识转化方法,我们以 WCHC 模式为基础,用英语和法语(加拿大国语)为服务提供者和女性艾滋病感染者开发了两个工具包。为了进行传播,我们分发了印刷广告材料,举办了 3 次全国性网络研讨会,并开展了 2 次虚拟能力建设系列培训:共有 315 人参加了网络研讨会,世界儿童健康中心的平均知识水平提高了 29%(标准差为 4.3%)。共有 131 名服务提供者参加了 22 次虚拟能力建设培训,讨论了 21 个临床案例。学员自我报告对 15/15 项能力(包括提供 WCHC 的能力)的信心有所增强。截至 2023 年 12 月,工具包已被下载 7766 次:我们成功开发了世界儿童健康中心工具包,并通过各种传播方式与不同的临床和社区受众分享。
{"title":"Dissemination of the Women-Centred HIV Care Model: A Multimodal Process and Evaluation.","authors":"Jill Koebel, Mina Kazemi, V Logan Kennedy, Priscilla Medeiros, Breklyn Bertozzi, Lindsay Bevan, Wangari Tharao, Carmen H Logie, Angela Underhill, Neora Pick, Elizabeth King, Mary Kestler, Mark H Yudin, Jesleen Rana, Adriana Carvalhal, Kath Webster, Melanie Lee, Shaz Islam, Valerie Nicholson, Mary Ndung'u, Manjulaa Narasimhan, Brenda Gagnier, Muluba Habanyama, Alexandra de Pokomandy, Angela Kaida, Mona Loutfy","doi":"10.1177/23259582231226036","DOIUrl":"10.1177/23259582231226036","url":null,"abstract":"<p><strong>Background: </strong>Using data from a national cohort study and focus groups, the Women-Centred HIV Care (WCHC) Model was developed to inform care delivery for women living with HIV.</p><p><strong>Methods: </strong>Through an evidence-based, integrated knowledge translation approach, we developed 2 toolkits based on the WCHC Model for service providers and women living with HIV in English and French (Canada's national languages). To disseminate, we distributed printed advertising materials, hosted 3 national webinars and conducted 2 virtual capacity-building training series.</p><p><strong>Results: </strong>A total of 315 individuals attended the webinars, and the average WCHC knowledge increased by 29% (SD 4.3%). In total, 131 service providers engaged in 22 virtual capacity-building training sessions with 21 clinical cases discussed. Learners self-reported increased confidence in 15/15 abilities, including the ability to provide WCHC. As of December 2023, the toolkits were downloaded 7766 times.</p><p><strong>Conclusions: </strong>We successfully developed WCHC toolkits and shared them with diverse clinical and community audiences through various dissemination methods.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582231226036"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10894538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139931678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) Study. 患者参与者对长效卡博特拉韦和利匹韦林实施情况的看法:欧洲卡博替拉韦和利匹韦林实施研究(CARISEL)的结果。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241269837
Cassidy A Gutner, Marc van der Valk, Joaquin Portilla, Eliette Jeanmaire, Leïla Belkhir, Thomas Lutz, Rebecca DeMoor, Rekha Trehan, Jenny Scherzer, Miguel Pascual-Bernáldez, Mounir Ait-Khaled, Beatriz Hernandez, Annemiek de Ruiter, Savita Bakhshi Anand, Emma L Low, Monica Hadi, Nicola Barnes, Nick Sevdalis, Perry Mohammed, Maggie Czarnogorski

Introduction: CARISEL is an implementation-effectiveness "hybrid" study examining the perspectives of people living with HIV-1 (patient study participants [PSPs]) on cabotegravir (CAB) plus rilpivirine (RPV) long-acting (LA) dosed every 2 months (Q2M) across 5 European countries.

Methods: PSPs completed questionnaires on acceptability (Acceptability of Intervention Measure), appropriateness (Intervention Appropriateness Measure), and feasibility (Feasibility of Intervention Measure) at their first (Month [M] 1), third (M4), and seventh (M12) injection visits. Semistructured qualitative interviews were also conducted.

Results: Overall, 437 PSPs were enrolled, of whom 430 received treatment. Median (interquartile range) age was 44 (37-51) years, 25.3% (n = 109/430) were female (sex at birth), and 21.9% (n = 94/430) were persons of color. Across time points, PSPs found CAB + RPV LA highly acceptable, appropriate, and feasible (mean scores ≥4.47/5). Qualitative data supported these observations.

Conclusions: PSPs found CAB + RPV LA Q2M to be an acceptable, appropriate, and feasible treatment option.

简介:CARISEL 是一项实施效果 "混合 "研究:CARISEL是一项实施效果 "混合 "研究,考察了欧洲5个国家的HIV-1感染者(患者研究参与者[PSPs])对卡博替拉韦(CAB)加利匹韦林(RPV)长效(LA)每2个月(Q2M)用药的看法:PSPs 在第一次(Month [M] 1)、第三次(M4)和第七次(M12)注射时填写了关于可接受性(干预可接受性测量)、适当性(干预适当性测量)和可行性(干预可行性测量)的问卷。此外,还进行了半结构化定性访谈:总共有 437 名 PSP 参与,其中 430 人接受了治疗。年龄中位数(四分位数间距)为 44(37-51)岁,25.3%(n = 109/430)为女性(出生时性别),21.9%(n = 94/430)为有色人种。在各个时间点,PSP 都认为 CAB + RPV LA 非常可接受、合适和可行(平均得分≥4.47/5)。定性数据支持这些观察结果:PSPs 认为 CAB + RPV LA Q2M 是一种可接受的、适当的和可行的治疗方案。
{"title":"Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) Study.","authors":"Cassidy A Gutner, Marc van der Valk, Joaquin Portilla, Eliette Jeanmaire, Leïla Belkhir, Thomas Lutz, Rebecca DeMoor, Rekha Trehan, Jenny Scherzer, Miguel Pascual-Bernáldez, Mounir Ait-Khaled, Beatriz Hernandez, Annemiek de Ruiter, Savita Bakhshi Anand, Emma L Low, Monica Hadi, Nicola Barnes, Nick Sevdalis, Perry Mohammed, Maggie Czarnogorski","doi":"10.1177/23259582241269837","DOIUrl":"10.1177/23259582241269837","url":null,"abstract":"<p><strong>Introduction: </strong>CARISEL is an implementation-effectiveness \"hybrid\" study examining the perspectives of people living with HIV-1 (patient study participants [PSPs]) on cabotegravir (CAB) plus rilpivirine (RPV) long-acting (LA) dosed every 2 months (Q2M) across 5 European countries.</p><p><strong>Methods: </strong>PSPs completed questionnaires on acceptability (Acceptability of Intervention Measure), appropriateness (Intervention Appropriateness Measure), and feasibility (Feasibility of Intervention Measure) at their first (Month [M] 1), third (M4), and seventh (M12) injection visits. Semistructured qualitative interviews were also conducted.</p><p><strong>Results: </strong>Overall, 437 PSPs were enrolled, of whom 430 received treatment. Median (interquartile range) age was 44 (37-51) years, 25.3% (n = 109/430) were female (sex at birth), and 21.9% (n = 94/430) were persons of color. Across time points, PSPs found CAB + RPV LA highly acceptable, appropriate, and feasible (mean scores ≥4.47/5). Qualitative data supported these observations.</p><p><strong>Conclusions: </strong>PSPs found CAB + RPV LA Q2M to be an acceptable, appropriate, and feasible treatment option.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241269837"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367594/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142108694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effects of COVID-19 Pandemic on HIV Service Provision in Ukraine. COVID-19 大流行对乌克兰提供艾滋病服务的影响。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241277649
Oleksandr Neduzhko, Tetiana Kiriazova, Oleksandr Zeziulin, Liudmyla Legkostup, Serhii Riabokon, Jack A DeHovitz, Kostyantyn Dumchev

Ukraine faced significant fluctuations in COVID-19 morbidity and mortality, alongside an escalating HIV epidemic. This mixed-methods study, conducted between February and August 2022, employed a sequential explanatory design combining a quantitative analysis of national data and qualitative interviews to investigate the pandemic's effects on HIV services in Ukraine. The observed trends confirmed that the pandemic significantly disrupted facility-based HIV testing due to logistical challenges, an increased burden on healthcare workers, and supply shortages. Meanwhile, community-based testing showed resilience, largely attributed to programmatic adjustments rather than the pandemic itself. The initiation of antiretroviral therapy declined, especially during initial lockdowns, reflecting diminished treatment capacities. Despite these challenges, telemedicine and home medication delivery innovations supported antiretroviral therapy adherence. Furthermore, improvements in viral load testing and suppression rates showed healthcare resilience. The study highlights the critical need for adaptable, sustainable healthcare strategies in crises, emphasized during the war with Russia.

乌克兰在艾滋病毒疫情不断升级的同时,还面临着 COVID-19 发病率和死亡率的大幅波动。这项混合方法研究于 2022 年 2 月至 8 月间进行,采用了一种顺序解释性设计,结合了对国家数据的定量分析和定性访谈,以调查疫情对乌克兰艾滋病服务的影响。观察到的趋势证实,由于后勤挑战、医护人员负担加重和供应短缺,大流行严重破坏了基于设施的艾滋病毒检测。与此同时,以社区为基础的检测显示出了韧性,这在很大程度上归因于计划调整而非大流行病本身。抗逆转录病毒疗法的启动率有所下降,尤其是在最初的封锁期间,这反映了治疗能力的减弱。尽管面临这些挑战,远程医疗和家庭送药创新为坚持抗逆转录病毒治疗提供了支持。此外,病毒载量检测和抑制率的提高也显示了医疗保健的适应能力。这项研究强调了在危机中对适应性强、可持续的医疗保健战略的迫切需要,这在与俄罗斯的战争中尤为突出。
{"title":"The Effects of COVID-19 Pandemic on HIV Service Provision in Ukraine.","authors":"Oleksandr Neduzhko, Tetiana Kiriazova, Oleksandr Zeziulin, Liudmyla Legkostup, Serhii Riabokon, Jack A DeHovitz, Kostyantyn Dumchev","doi":"10.1177/23259582241277649","DOIUrl":"10.1177/23259582241277649","url":null,"abstract":"<p><p>Ukraine faced significant fluctuations in COVID-19 morbidity and mortality, alongside an escalating HIV epidemic. This mixed-methods study, conducted between February and August 2022, employed a sequential explanatory design combining a quantitative analysis of national data and qualitative interviews to investigate the pandemic's effects on HIV services in Ukraine. The observed trends confirmed that the pandemic significantly disrupted facility-based HIV testing due to logistical challenges, an increased burden on healthcare workers, and supply shortages. Meanwhile, community-based testing showed resilience, largely attributed to programmatic adjustments rather than the pandemic itself. The initiation of antiretroviral therapy declined, especially during initial lockdowns, reflecting diminished treatment capacities. Despite these challenges, telemedicine and home medication delivery innovations supported antiretroviral therapy adherence. Furthermore, improvements in viral load testing and suppression rates showed healthcare resilience. The study highlights the critical need for adaptable, sustainable healthcare strategies in crises, emphasized during the war with Russia.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241277649"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11384520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patients' and Care Providers' Reported Barriers and Suggestions for Improving HIV Viral Load Testing in Tanzania: A Qualitative Study in Dar es Salaam. 坦桑尼亚患者和护理人员报告的障碍及改进 HIV 病毒载量检测的建议:达累斯萨拉姆定性研究》。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241273385
Peter M Karoli, Elizabeth H Shayo, Grace A Shayo, Zenais A Kiwale, Claudia A Hawkins, Sylvia F Kaaya, Lisa R Hirschhorn

The study explores barriers and suggestions for improving viral load testing (VLT) uptake in Tanzania, revealing that only 58% of patients receive VLT annually, contrary to the Tanzanian National Guidelines toward the 95-95-95 UNAIDS targets. Twelve individual interviews and three patient-focus groups were conducted as part of a qualitative study conducted in six human immunodeficiency virus (HIV) clinics in Dar es Salaam to identify potential suggestions for access enhancement, as well as barriers to VLT uptake. Using King's theory of goal attainment, we found that missing appointments was the primary individual barrier to VLT uptake, along with limited knowledge among individuals living with HIV. Participants also face system-level barriers, such as a lack of integrated care and evening service availability. The study suggests that, despite challenges, there is potential for improvement in the uptake and quality of VLT services in Tanzanian public health facilities through a holistic approach.

该研究探讨了提高坦桑尼亚病毒载量检测(VLT)接受率的障碍和建议,结果显示,每年只有 58% 的患者接受病毒载量检测,这与坦桑尼亚国家指导方针中 95-95-95 联合国艾滋病规划署目标背道而驰。作为定性研究的一部分,我们在达累斯萨拉姆的六家人类免疫缺陷病毒(HIV)诊所进行了 12 次个人访谈和 3 次患者焦点小组访谈,以确定提高 VLT 使用率的潜在建议以及 VLT 接受率的障碍。利用金的目标实现理论,我们发现错过预约是个人接受 VLT 的主要障碍,此外,艾滋病毒感染者对 VLT 的了解也很有限。参与者还面临着系统层面的障碍,如缺乏综合护理和晚间服务。这项研究表明,尽管存在挑战,但通过综合方法,坦桑尼亚公共卫生机构仍有可能提高自愿咨询和治疗服务的利用率和质量。
{"title":"Patients' and Care Providers' Reported Barriers and Suggestions for Improving HIV Viral Load Testing in Tanzania: A Qualitative Study in Dar es Salaam.","authors":"Peter M Karoli, Elizabeth H Shayo, Grace A Shayo, Zenais A Kiwale, Claudia A Hawkins, Sylvia F Kaaya, Lisa R Hirschhorn","doi":"10.1177/23259582241273385","DOIUrl":"10.1177/23259582241273385","url":null,"abstract":"<p><p>The study explores barriers and suggestions for improving viral load testing (VLT) uptake in Tanzania, revealing that only 58% of patients receive VLT annually, contrary to the Tanzanian National Guidelines toward the 95-95-95 UNAIDS targets. Twelve individual interviews and three patient-focus groups were conducted as part of a qualitative study conducted in six human immunodeficiency virus (HIV) clinics in Dar es Salaam to identify potential suggestions for access enhancement, as well as barriers to VLT uptake. Using King's theory of goal attainment, we found that missing appointments was the primary individual barrier to VLT uptake, along with limited knowledge among individuals living with HIV. Participants also face system-level barriers, such as a lack of integrated care and evening service availability. The study suggests that, despite challenges, there is potential for improvement in the uptake and quality of VLT services in Tanzanian public health facilities through a holistic approach.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241273385"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11368890/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142004501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the International Association of Providers of AIDS Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1